Biofrontera Inc. BFRI
1.18
(0.02)
(1.67%)
as of 25 Sep
- Market cap
- $17.8M
- P/E
- 0.0×
Follow BFRI
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 28.17 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.14 | 0.16 | 0.13 | 0.62 | 2.75 | 1.94 | 1.94 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(2.44) | (5.91) | (0.49) | (2.16) | (3.16) | (28.99) | (28.99) | — |
P/B ratio |
0.55 | 1.36 | 0.90 | 0.75 | 5.84 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.74 | 1.37 | 2.00 | 0.86 | 8.40 | 0.00 | 0.00 | — |
EV/Sales |
0.10 | 0.12 | 0.22 | (0.30) | 1.73 | 1.85 | 1.85 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.32) | (0.44) | (0.30) | 0.53 | (1.56) | (5.25) | (5.25) | — |
EV/FCF |
(0.32) | (0.44) | (0.30) | 0.53 | (1.56) | (5.25) | (5.25) | — |
Quick Ratio |
1.15 | 0.93 | 0.36 | 1.68 | 2.67 | 2.57 | 1.03 | — |
Current Ratio |
1.52 | 1.72 | 1.28 | 2.06 | 3.36 | 4.43 | 2.00 | — |
Net Debt/EBITDA |
0.17 | 0.11 | (0.11) | 1.52 | 1.00 | 0.89 | (2.17) | — |
Debt/Assets |
16.07% | 18.54% | 13.98% | 2.65% | 0.00% | 0.00% | 132.86% | 0.00% |
Debt/Equity |
0.44 | 0.92 | 0.81 | 0.06 | 0.00 | 0.00 | (1.27) | — |
Asset Turnover |
1.65 | 1.49 | 0.86 | 0.55 | 0.62 | 0.71 | 1.82 | — |
Operating CF/Net income |
1.27 | 0.58 | 1.24 | 25.31 | 0.71 | 1.13 | 3.43 | — |
Capex/Depreciation |
0.00 | (0.05) | 0.00 | (0.03) | (0.02) | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (141.30%) | (384.98%) | (140.43%) | (3.63%) | (439.39%) | 90.24% | 90.20% | — | |
| (41.59%) | (70.99%) | (51.08%) | (1.23%) | (97.50%) | (41.55%) | (76.39%) | — | |
ROIC |
(81.82%) | (410.70%) | (194.79%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(126.24%) | (202.75%) | (393.11%) | (2.85%) | (114.80%) | (70.77%) | (89.80%) | — |
Average Days of Receivables |
63.81 | 51.98 | 55.30 | 94.27 | 188.27 | 63.69 | 66.72 | — |
Research and Development Expense of Revenue |
8.92% | 5.60% | 0.23% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
92.00% | 90.66% | 114.84% | 125.10% | 154.39% | 96.12% | 107.05% | — |
Intangible Assets out of Total Assets |
0.09 | 0.00 | 0.09 | 0.06 | 0.06 | 0.16 | 0.15 | 0.00 |
Share Based Compensation of Revenue |
2.28% | 2.73% | 3.07% | 6.46% | 0.54% | 0.00% | 0.00% | — |
Graham Net Nets |
0.00 | 0.50 | (0.01) | 0.90 | 0.07 | (0.64) | (0.64) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 17.46 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(180.70%) | (295.12%) | (565.00%) | 3.55% | (55.71%) | (67,752.82%) | (67,752.82%) | — |
Free Cash Flow Yield |
(230.48%) | (170.97%) | (575.11%) | (90.90%) | (40.35%) | (18.11%) | (18.11%) | — |
Revenue per Share |
4.10 | 6.77 | 22.03 | 27.13 | 54.72 | 17,135.45 | 43.13 | — |
Operating CF per Share |
(1.31) | (1.86) | (16.10) | (15.33) | (60.66) | (11,244.55) | (62.07) | — |
Capex per Share |
0.00 | (0.01) | 0.00 | (0.04) | (0.02) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(1.31) | (1.87) | (16.10) | (15.36) | (60.69) | (11,244.55) | (62.07) | — |
Cash per Share |
0.63 | 1.07 | 0.92 | 26.26 | 55.73 | 7,345.45 | 12.03 | — |
Shareholders Equity per Share |
1.03 | 0.80 | 3.10 | 22.59 | 25.74 | 5,298.18 | (49.72) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.03 | 0.80 | 3.10 | 22.59 | 25.74 | 5,298.18 | (49.72) | — |
Free Cash Flow |
(13.36) | (10.33) | (24.90) | (16.24) | (26.73) | (12.37) | (37.68) | — |
Working Capital |
6.19 | 8.68 | 4.99 | 22.25 | 32.59 | 15.16 | 11.73 | — |
Capital Expenditures |
0.00 | (0.06) | 0.00 | (0.04) | (0.01) | — | (0.54) | — |
Net Current Asset Value |
0.00 | 3.03 | (0.06) | 16.13 | 4.54 | 1.27 | (35.46) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.46 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
(25.26%) | (47.58%) | (59.09%) | (2.23%) | (156.49%) | (58.29%) | (41.95%) | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.40 | 14.36 | 7.94 | 5.75 | 2.02 | 1.52 | 1.33 | — |
Cash ROIC |
(72.28%) | (71.66%) | (247.37%) | (30.96%) | (75.19%) | (91.59%) | (249.17%) | — |
Accounts Receivable Turnover |
6.62 | 7.12 | 5.42 | 2.89 | 3.07 | 4.67 | 6.48 | — |
Accounts Payable Turnover |
1.58 | 2.30 | 3.01 | 8.60 | 9.60 | 1.90 | 2.74 | — |
Inventory Turnover |
2.72 | 2.12 | 1.93 | 2.61 | 2.21 | 1.03 | 1.49 | — |
Average Days of Payables |
221.92 | 141.24 | 188.44 | 62.26 | 26.93 | 69.01 | 218.13 | — |
Days of Inventory on Hand |
47.47 | 130.37 | 228.24 | 172.30 | 127.70 | 285.49 | 292.56 | — |
Average Receivables |
6.30 | 5.24 | 6.28 | 9.92 | 7.86 | 4.04 | 4.04 | — |
Average Payables |
6.93 | 8.10 | 5.80 | 1.77 | 1.33 | 4.76 | 4.76 | — |
Average Inventory |
4.04 | 8.78 | 9.04 | 5.81 | 5.77 | 8.79 | 8.79 | — |
Average Assets |
25.33 | 25.02 | 39.41 | 52.05 | 38.68 | 26.45 | 14.38 | — |
Average Common Equity |
7.46 | 4.61 | 14.34 | 17.61 | 8.58 | (12.18) | (12.18) | — |
Columns are period end dates